tiprankstipranks
Genscript Biotech Announces Deconsolidation of Legend Biotech
Company Announcements

Genscript Biotech Announces Deconsolidation of Legend Biotech

Genscript Biotech (HK:1548) has released an update.

Pick the best stocks and maximize your portfolio:

Genscript Biotech has announced the deconsolidation of its subsidiary, Legend Biotech, following changes to their deposit agreement. This strategic shift means Legend Biotech will now be classified as an associate, with Genscript recognizing its investment using the equity method. The move is expected to result in a one-time tax-free gain for Genscript, reflecting the fair market value of its share in Legend Biotech.

For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech’s CARVYKTI® Boosts Multiple Myeloma Results
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Announces CEO Resignation and Leadership Changes
TipRanks HongKong Auto-Generated NewsdeskGenscript Biotech Aligns Interests with Restricted Share Grant
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App